A first-of-its-kind treatment to slow the symptoms of early Alzheimer's disease has been approved for use in Australia.
Share this @internewscast.com

A first-of-its-kind treatment to slow the symptoms of early Alzheimer’s disease has been approved for use in Australia.

The Therapeutic Goods Administration has approved the pharmaceutical company Eli Lilly’s medication, Kisunla (donanemab), for individuals experiencing early symptomatic Alzheimer’s, particularly those who exhibit amyloid plaque, or protein clusters, in the brain.

A build-up of plaque causes issues associated with the neurodegenerative disease, like memory loss and impaired thinking.

A first-of-its-kind treatment to slow the symptoms of early Alzheimer's disease has been approved for use in Australia.
A first-of-its-kind treatment to slow the symptoms of early Alzheimer’s disease has been approved for use in Australia. (Supplied)

The drug is administered through a monthly infusion over a maximum of 18 months and works to clear plaque from the brain.

According to Eli Lilly, Kisunla is the first novel therapy for early-stage Alzheimer’s in 25 years and the first in Australia aimed at addressing the root cause of the condition.

An estimated 600,000 Australians currently live with Alzheimer’s with about 450,000 of those able to be tested to assess their eligibility.

This has been hailed as a breakthrough by the researcher who led the clinical trials in Australia. 

Professor Michael Woodward, Head of Dementia Research at Austin Health, expressed, “As clinicians, we’ve been anticipating the opportunity to provide patients with a treatment like this for a very long time.”

A first-of-its-kind treatment to slow the symptoms of early Alzheimer's disease has been approved for use in Australia.
An application to include the drug on the PBS will be reviewed in July. (Supplied)

“There is an important window of opportunity when it is possible to detect, diagnose and treat Alzheimer’s disease with the goal that patients can maintain their independence for longer.

“The availability of donanemab is a major development at a time when more and more Australians and their families are being impacted by this insidious disease.”

The drug is not listed on the Pharmaceutical Benefits Scheme (PBS), meaning that it would cost patients $4700 per session or $84,600 over the recommended 18 months.

An application to include the drug on the PBS will be reviewed in July.

Donanemab is approved in the United States, Japan, China, the United Kingdom, United Arab Emirates, Qatar, Kuwait, Bahrain, Singapore, Taiwan, Brazil, Mexico and Australia.

Share this @internewscast.com
You May Also Like
Thunderstorms coming for parts of NSW

Severe Thunderstorms Bring Hail to Much of New South Wales

A pool of unstable cold air in the region whipped up some…
PM leads charm offensive as Wallabies clash with Fiji

Prime Minister Launches Diplomatic Push Amid Wallabies’ Showdown with Fiji

They are neighbours, friends and in many cases family, but now the…
'Extraordinary figure' in motorsport killed in Taronga Zoo bike crash

Prominent Motorsport Figure Tragically Dies in Taronga Zoo Bike Accident

A passionate cyclist who lost his life in a collision with a…

Over 50% of Senior Australians Support Labor’s $3 Million Superannuation Tax Proposal

More than half of older Australians support increasing taxes on high superannuation…
The US economy has shrunk in the last quarter, with Donald Trump's trade war blamed.

Trump’s Temporary Tariff Pause Nears Its End, Leading to Uncertainty

The 90-day deadline President Donald Trump set for countries to make trade…
The knuckledusters seized at Perth Airport (inset) and the domestic terminal.

Western Australian Man Faces Court Over Alleged Attempt to Board Flight with Knuckle Dusters

A West Australian man is set to appear in Perth Magistrates Court…
Tammy Hembrow (pictured) is heading for divorce after splitting from her husband of just seven months, Matt Zukowski

Tammy Hembrow Puzzles Fans by Wearing Her Diamond Wedding Ring After Splitting from Husband Matt Zukowski

Tammy Hembrow is heading for divorce after splitting from her husband of…
Premier's pledge after visiting fire-damaged synagogue

Premier Promises Support Following Visit to Fire-Hit Synagogue

Victoria Premier Jacinta Allan has pledged to extend all necessary support to…
Friends of Sydney socialite and stylist Kelly Smythe (pictured) are growing concerned in the wake of her shocking forgery scam scandal

Rising Worry for Ex-Sydney Socialite and Fashion Icon Kelly Smythe Following Alleged Forgery Scandal Accusations

Friends of Sydney socialite and stylist Kelly Smythe are growing concerned in…

Tour de France: Van der Poel Outpaces Pogacar in Thrilling Hilltop Stage Victory

Alpecin’s Mathieu van der Poel has edged Tadej Pogacar to win the…

“‘Lives at Risk’: The Impact of Trump’s Actions on Struggling Clinics”

Fadumo (not her real name), a widowed mother of three, endured a…

Innovative Solution Unveiled to Address a Major Cause of Death in Australia

Lung cancer is Australia’s fifth most diagnosed cancer, but causes the greatest…